Drawing for MOSAIC - MULTI OMICS SPATIAL ATLAS IN CANCER

USPTO serial 97483655

MOSAIC - MULTI OMICS SPATIAL ATLAS IN CANCER

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MEBANE, ANASTASIA XAVIERA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MOSAIC - MULTI OMICS SPATIAL ATLAS IN CANCER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew D. Bochner

Andrew D. Bochner Bochner PLLC1040 Avenue of the Americas15th FloorNew York, NY 10018

Goods and services

ClassDescriptionStatusFirst use
009downloadable and recorded databases in the field of medical research and development; downloadable and recorded artificial intelligence computer and mobile application software for providing online databases and processing, accessing, and inputting medical information in the field of medical research and development; downloadable and recorded artificial intelligence computer and mobile application software for healthcare, namely, to process, access, and input medical information in the field of oncology; downloadable and recorded software as a medical device SaMD, for providing online databases in the field of medical research and development; all the aforementioned goods excluding physical measuring instruments, none of the aforementioned goods for or in connection with the recording, transmission and reproduction of audio signalsACTIVE—
035Computerized file management in the field of medical research and development; Compilation of statistical data relating to medical research; Automated processing of medical dataACTIVE—
042Medical research; Medical research in the field of oncology; Scientific research for medical purposes in the area of cancerous diseases, all these services excluding physical measuring instruments; providing online, non-downloadable databases in the field of medical research and development; providing online, non-downloadable artificial intelligence software for providing online databases and processing, accessing, and inputting medical information in the field of medical research and development; providing online, non-downloadable artificial intelligence software for healthcare, namely, to process, access, and input medical information in the field of oncologyACTIVE—
044Medical services; Medical diagnostic services, namely, medical diagnostic testing, analysis, monitoring, and reporting services, all these services excluding physical measuring instruments; providing an internet-based database of genomic and pseudonomyzed medical data, medical research and medical developmentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 11, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 11, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 2, 2025EX2GSOU EXTENSION 2 GRANTED—
Oct 2, 2025EXT2SOU EXTENSION 2 FILED—
Oct 2, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 9, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 9, 2025EX1GSOU EXTENSION 1 GRANTED—
Apr 9, 2025EXT1SOU EXTENSION 1 FILED—
Apr 8, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 8, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 13, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 13, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 26, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 26, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 26, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 26, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 26, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 24, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 10, 2024EXPTEXPARTE APPEAL TERMINATED—
Jul 10, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 10, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Jul 10, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 10, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 10, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 30, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 30, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 29, 2024ALIEASSIGNED TO LIE—
Nov 9, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 9, 2023EXPIEX PARTE APPEAL-INSTITUTED—
Nov 9, 2023JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Nov 9, 2023EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Aug 14, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 14, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 14, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 19, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 19, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 19, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 24, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 24, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 24, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 14, 2023DOCKASSIGNED TO EXAMINER—
Sep 28, 2022TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Sep 28, 2022PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jul 20, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 4, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance